Meanwhile, demand for vaccines targeting respiratory syncytial virus are down in the U.S. Also, if you are uncertain about whether you might have covid or the flu, the newly approved at-home Healgen ...

In a report released today, Rajan Sharma from Goldman Sachs maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

GSK said a dose of its RSV vaccine protected against illness over three years, according to new data presented at the CHEST ...

While recent CDC guidance threatens to shrink the market for a new class of immunizations, GSK continues to build the case ...

Mumbai: A retired GlaxoSmithKline (GSK) employee, Ashok Shetty, on Monday reported a home burglary involving the theft of ...

Millions of people who bought DNA tests from genetic testing service 23andme have been urged to delete their personal data ...

ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries ...

GSK, Sanofi and CSL Ltd have secured $72 million from the US government to ramp up production of bird flu vaccines, Reuters ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

The life sciences developer acquired the site as part of a master lease agreement with seller MIT that expires in 2099.

EU regulators are considering withdrawing market authorizations for two hair loss and enlarged prostate treatments over ...